Pulmonology Devices Market is estimated to cross worth US$ 3.8 Billion by 2033, at a growth rate of 10.3% CAGR through 2033 end

The pulmonology devices market in the UK is anticipated to witness growth due to the increasing prevalence of pulmonary disorders. However, the United States currently holds the leading position in the global market for pulmonology devices and is projected to maintain high demand throughout the forecast period.

/EIN News/ — NEWARK, Del, May 19, 2023 (GLOBE NEWSWIRE) — The growing popularity of the screening and therapeutic pulmonology devices market is expected to persist as the world’s elderly population grows. This is projected to open up novel opportunities for the pulmonology devices market to grow over the forecast duration, which is expected to grow at a CAGR of close to 10.3% through 2033. In 2023, the market for pulmonology devices is anticipated to reach US$ 1.4 Billion. By 2033, the market is anticipated to reach US$ 3.8 Billion.

According to the World Health Organization (WHO), the overall number of cases has risen to 113,820,168, with a projection of 2,527,891 fatalities as of March 1, 2021. Over the coming years, the increasing respiratory disease challenges are projected to create significant growth possibilities in the pulmonology devices market.

Every year, the incidence of respiratory disorders such as lung cancer, asthma, chronic obstructive pulmonary disorder (COPD), and cystic fibrosis rises, fueling the market growth. As per the World Cancer Research Fund, lung cancer was one of the leading causes of death in 2018, with 2 Million new cases reported that year.

Drivers and Challenges have an Impact on Market Dynamics, which can Impact your Business. Find more details in our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Key Takeaways:

  • In 2023, the global market is expected to be worth US$ 1.4 Billion.
  • Over the next few decades, the Indian market is anticipated to grow at a CAGR of 10.9%.
  • In 2022, North America had a revenue share of more than 32%.
  • Over the next few decades, the market in the United Kingdom is expected to grow at an 8.7% CAGR.
  • In 2022, the segment lung cancer held a market share of 30.82%.

” As a result of the increasing prevalence of pulmonary disease, there is a greater need for cutting-edge methods for precise diagnosis and treatment. Some of the most prevalent drivers of respiratory conditions are inhaling nicotine, air pollution, and industrial and chemical pollutants, which reduce air quality and raise the geriatric population.” – says an FMI analyst.

Competitive Landscape:

Some of the market’s strongest competitors are making investments in studies and research (R&D) in order to facilitate the provision of an extensive selection of leather manufactured in a variety of colors and substances for a variety of applications. Companies hope to keep up with the changing environment by doing so. For instance,

  • Noah Medical, a California-based medical robotics startup, declared on Wednesday that it has raised $150 Million in additional financing for April 2023. Softbank Vision the fund and Prosperity7 Ventures co-led the funding initiative. The shareholders in the round included Hillhouse Capital, Sequoia Capital China, and UpHonest Capital.
  • FUJIFILM India revealed a collaboration with the Department of Pulmonary Medicine, Thoracic Oncology Disease Management Group, Tata Memorial Centre (TMC), Mumbai, in April 2023. The collaboration intends to build an educational centre at TMC.

Key Players:

  • Boston Scientific Corporation
  • CONMED Corporation
  • Olympus Corporation
  • Cook Medical Incorporated
  • Medi-Globe GmbH
  • Ambu A/S
  • Verathon, Inc
  • United Medical Surgical Services Ltd
  • Hunan Vathin
  • Micro-Tech (Nanjing) Co., Ltd
  • Merit Medical Systems

Are you looking for more details about the latest trends, drivers, and challenges? Speak to Our Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-13036

More Valuable Insights:

Future Market Insights, in its new offering, presents an unbiased analysis of the Global Pulmonology Devices Market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights by Product (Pulmonary Biopsy Devices, Endobronchial Ultrasound (EBUS) Needles, Airway Stents, Airway Extraction Baskets, Single-Use Bronchoscopes), Indication (Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis), End User & Region.

Market by Categorization:

By Product:

  • Pulmonary Biopsy Devices
    • Single- Use Biopsy Forceps
    • Cytology Brushes
    • Microbiology Brushes
  • Endobronchial Ultrasound (EBUS) Needles
    • Endobronchial Ultrasound Fine Biopsy Needles
    • Endobronchial Ultrasound Transbronchial Aspiration Needles
  • Airway Stents
    • Silicon Stents
    • Nitinol Stents
    • Stainless Steel Stents
  • Airway Extraction Baskets
  • Single-Use Bronchoscopes

By Indication:

  • Lung Cancer
  • COPD
  • Foreign Body Extraction
  • Tracheal and Bronchial Stenosis
  • Others

By End User:

  • Hospitals
  • Pulmonology Clinics
  • Ambulatory Surgical Centers

Buy Now and Gain Access to Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/13036

Table of Content (ToC):

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

Request Full TOC of Report: https://www.futuremarketinsights.com/toc/rep-gb-13036

Have a Look at Related Research Reports in the Healthcare Domain:

CMO/CDMO Market Size: The global CMO/CDMO market is estimated to be valued at US$ 22.5 Billion in 2023. The market is projected to reach US$ 39.4 Billion by 2033, exhibiting a CAGR of 5.7% from 2023 to 2033.

Digital Psychotherapeutics Market Share: The global digital psychotherapeutics market size is projected to be worth US$ 1.06 Billion in 2023. Over the next ten years, global digital psychotherapeutics demand is likely to accelerate at 27.6% CAGR. By 2033, the total market value is expected to surpass US$ 12.2 Billion.

Clinical Research Organization Market Growth: According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.

Mastectomy Reconstruction Implants Market Trend: According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at US$ 1.95 Billion in 2022 and is set to reach US$ 4.69 Billion by 2033.

Esophageal Implant Market Forecast: The global esophageal implant market size is estimated to reach US$ 147.0 Million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, the total market value is likely to exceed US$ 280.2 Million.

Fecal Pancreatic Elastase Testing Market Sales: The fecal pancreatic elastase testing market is expected to increase from US$ 15,306.7 Million in 2023 to US$ 31,842.3 Million by 2033. The market is likely to capture a 7.6% CAGR from 2023 to 2033.

Nasal Allergy Treatment Market Analysis: The global nasal allergy treatment market enjoys a valuation of US$ 6.6 Billion in 2022, and it is further projected to expand at a CAGR of 6.7% over the forecasted years.

Seasonal Allergy Market Outlook: The global seasonal allergy market enjoys a valuation of US$ 1.15 Billion in 2022, and it is further projected to expand at a CAGR of 7.8% over the forecasted years.

Body Fat Reduction Market Volume: The body fat reduction market is expected to expand its roots at a steady CAGR of 9.6% during the forecast period. The market is likely to hold a revenue of US$ 10.65 Billion in 2023 while it is anticipated to cross a value of US$ 25.6 Billion by 2033.

Vaginal Antifungals Market Application: The global vaginal antifungals market enjoys a valuation of US$ 1.09 Billion in 2022, and it is further projected to expand at a CAGR of 4.5% over the forecasted years

About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: [email protected]
Source: Growing Prevalence of Respiratory Disorders Will Push Pulmonology Devices Market to Present Significant Growth During 2020-2030 – Future Market Insights, Inc.


Primary Logo



Originally published at https://www.einpresswire.com/article/634692305/pulmonology-devices-market-is-estimated-to-cross-worth-us-3-8-billion-by-2033-at-a-growth-rate-of-10-3-cagr-through-2033-end-future-market